Milburn, Geoffrey

Lead design engineer at Axine Water Technologies responsible for process and mechanical design of electrochemical oxidation systems.

Joined:

About Milburn, Geoffrey

Lead design engineer at Axine Water Technologies responsible for process and mechanical design of electrochemical oxidation systems.

Milburn, Geoffrey

Lead design engineer at Axine Water Technologies responsible for process and mechanical design of electrochemical oxidation systems.

Titles from this speaker

Description: Removal of Fluorinated Active Pharmaceutical Ingredients Using Membrane...

Removal of Fluorinated Active Pharmaceutical Ingredients Using Membrane Concentration and Electrochemical Oxidation

Abstract

A major source of pharmaceuticals in the environment is the discharge of wastewater contaminated with active pharmaceutical ingredients (API) at manufacturing facilities. API wastewaters are often segregated and trucked offsite for disposal. Electrochemical oxidation (EOx) allows onsite treatment of pharmaceutical wastewaters including stable fluorinated APIs without generating secondary waste streams, eliminating the need for offsite disposal. The EOx process can break extremely stable bonds and is ideally suited for API removal. Fundamentals of electrochemical oxidation, catalyst selection, and typical operating conditions are reviewed. EOx systems are typically operated as batch reactors with first order kinetics dominating API removal rate, and complementary processes can improve performance. Process trains integrating EOx with concentration/separation technologies are illustrated. A case study and operating data are presented of an API removal system currently operating at a Fortune 500 pharmaceutical manufacturer utilizing an integrated ultrafiltration, reverse osmosis, and EOx treatment train.

Electrochemical oxidation (EOx) allows onsite treatment of pharmaceutical wastewater containing stable fluorinated compounds without generating secondary waste streams, eliminating the need to truck wastewater offsite for disposal. Concentration of wastewater can improve the performance of EOx. Catalyst selection, process design, and a case study of a wastewater treatment system at a Fortune 500 pharmaceutical manufacturer incorporating ultrafiltration, reverse osmosis, and EOx is discussed.

SpeakerMilburn, Geoffrey

Presentation time

13:30:00

13:50:00

Session time

13:30:00

15:00:00

SessionRemoving Emerging Contaminants: Beyond PFAS

Session locationRoom S404a - Level 4

TopicIntermediate Level, Research and Innovation

Author(s)

Milburn, Geoffrey

Author(s)G. Milburn 1; V. Leung 2 ; G. Milburn 1;

Author affiliation(s)Axine Water 1; Axine Water 2 ;

SourceProceedings of the Water Environment Federation

Document typeConference Paper

PublisherWater Environment Federation

Print publication date Oct 2023

DOI10.2175/193864718825159229

Volume / Issue

Content sourceWEFTEC

Word count13

Base text size -

Milburn, Geoffrey

About Milburn, Geoffrey

My Recent Activity